Keryx Biopharmaceuticals, Inc. et al v. Watson Laboratories, Inc. et al
| Keryx Biopharmaceuticals, Inc. and Panion & BF Biotech, Inc. |
| Watson Laboratories, Inc., Teva Pharmaceutical Industries Limited and Teva Pharmaceuticals USA, Inc. |
| 1:2019cv00885 |
| May 10, 2019 |
| US District Court for the District of Delaware |
| Leonard P Stark |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 28, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Pro Hac Vice Attorney Lisa J. Pirozzolo, Emily R. Whelan for Keryx Biopharmaceuticals, Inc., for Panion & BF Biotech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Pro Hac Vice Attorney Timothy A. Cook, Kevin S. Prussia for Keryx Biopharmaceuticals, Inc., for Panion & BF Biotech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Filing 13 ANSWER to #9 Answer to Complaint, Counterclaim -- Answer to Counterclaims -- by Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc..(Raucci, Anthony) |
SO ORDERED, re #12 MOTION for Pro Hac Vice Appearance of Attorney Lisa J. Pirozzolo, Emily R. Whelan, Kevin S. Prussia and Timothy A. Cook filed by Panion & BF Biotech, Inc., Keryx Biopharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 6/13/19. (ntl)
|
| Filing 12 MOTION for Pro Hac Vice Appearance of Attorney Lisa J. Pirozzolo, Emily R. Whelan, Kevin S. Prussia and Timothy A. Cook - filed by Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc.. (Raucci, Anthony) |
|
SO ORDERED, re #8 Stipulation Dismissing Teva Pharmaceutical Industries Ltd. Signed by Judge Leonard P. Stark on 6/3/19. (ntl)
|
| Filing 11 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Filing 10 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceuticals USA, Inc., Other Affiliate Teva Pharmaceutical Industries Ltd. for Watson Laboratories, Inc., Watson Laboratories, Inc. filed by Watson Laboratories, Inc.. (Keller, Karen) |
| Filing 9 ANSWER to #1 Complaint, , COUNTERCLAIM against All Plaintiffs by Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc..(Keller, Karen) |
| Filing 8 STIPULATION Dismissing Teva Pharmaceutical Industries Limited by Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc.. (Raucci, Anthony) |
| Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:19-cv-00884-LPS, 1:19-cv-00885-LPS(nmg) |
| Filing 7 Return of Service Executed by Panion & BF Biotech, Inc., Keryx Biopharmaceuticals, Inc.. Teva Pharmaceuticals USA, Inc. served on 5/13/2019, answer due 6/3/2019. (Raucci, Anthony) |
| Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceutical Industries Limited on 5/13/2019; Teva Pharmaceuticals USA, Inc. on 5/13/2019; Watson Laboratories, Inc. on 5/13/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lak) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Panion & BF Biotech, Inc. (lak) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Akebia Therapeutics, Inc. for Keryx Biopharmaceuticals, Inc. filed by Keryx Biopharmaceuticals, Inc. (lak) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See attachment. (lak) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/1/2019. Date of Expiration of Patent: See attachment.Thirty Month Stay Deadline: 10/1/2021. (lak) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT - filed against Teva Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2640154.) - filed by Panion & BF Biotech, Inc., Keryx Biopharmaceuticals, Inc.. (Attachments: #1 Exhibit A-L, #2 Civil Cover Sheet) (lak) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
